Indolyl derivatives as liver-X-receptor modulators

Details for Australian Patent Application No. 2005238176 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Panday, Narendra; Schulz-Gasch, Tanja; Ratni, Hasane; Wright, Matthew Blake; Dehmlow, Henrietta; Kuhn, Bernd

Agent Spruson & Ferguson

Pub. Number AU-B-2005238176

PCT Pub. Number WO2005/105791

Priority 04101889.6 03.05.04 EP

Filing date 26 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 27 November 2008

International Classifications

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/12 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/30 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105791 Priority application(s): WO2005/105791

27 November 2008 Application Accepted

  Published as AU-B-2005238176

26 March 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238178-Thienopyridazines as IKK inhibitors

2005238173-Biologically active peptide vapeehptllteaplnpk derivatives